• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA IDL SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA IDL SET Back to Search Results
Model Number 12320
Device Problems Gas/Air Leak (2946); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Anemia (1706); Low Blood Pressure/ Hypotension (1914); Tachycardia (2095); No Known Impact Or Consequence To Patient (2692); Test Result (2695)
Event Date 03/12/2020
Event Type  malfunction  
Manufacturer Narrative
Investigation: the customer performed a custom prime for this procedure and the leurs were tight.The customer also reported that the patients mother was concerned the patient received air, but it has not been confirmed if that did occur.Investigation is in process.A follow-up report will be provided.
 
Event Description
The customer reported that during a continuous mononuclear cell (cmnc) collection using a spectra optia device, there were air bubbles seen in the tubing towards the return access.In the blood warmer tubing line, microbubbles that formed into a big bubble was noted and the procedure was stopped.The patient remained alert and awake; no hypoxemia was reported.An ecg was ordered.A cbc was drawn, which showed severe anemia and worsening thrombocytopenia.The patient received packed red blood cells because the hemoglobin dropped from 8 to 5.5.Saline was provided to the patient because the patient had gotten tachycardic and hypotensive.Per the customer no medical intervention was required and the air was aspirated with a syringe after pausing the procedure.The patient was admitted for monitoring and for a 2nd collection and is continuing oncology road map or treatment plan.The disposable set is not available for return because it was discarded by the customer.
 
Manufacturer Narrative
This report is being filed to provide additional information in h.6 and h.10 investigation: a review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.During therapeutic procedures on the spectra optia systems, the replacement fluid may be cold.If it is not allowed to warm to room temperature, and if the blood returned to the patient is warmed using a blood warmer, air bubbles may form during warming.They are usually described as chains of very small bubbles or foam, which tend to rise toward the top of the tubing and may coalesce to form larger bubbles.This phenomenon, called "outgassing," occurs because gasses are more soluble in low temperature liquids than in liquids at higher te mperatures.If air is available to dissolve in a fluid at a low storage temperature and approaches its equilibrium solubility at that temperature, the air will come out of the solution when the fluid is warmed because its solubility is exceeded at the higher temperature.Outgassing is sometimes also seen when blood or replacement fluids are re-warmed by the blood warmer in procedures.Correction: the terumo bct clinical specialist provided the operator with outgassing information and the blood warmer ifu for tubing connections.Investigation is in process.A follow up report will be provided.
 
Manufacturer Narrative
This report is being filed to provide additional information in b.5, h.6 and h.10.Root cause: based on information provided in the clinical findings, the root cause of the air bubbles noted in blood warmer tubing are a result of outgassing.
 
Event Description
Per the customer, the patient was stable at the end of the procedure and no medical intervention was required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA IDL SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
MDR Report Key10123715
MDR Text Key200864993
Report Number1722028-2020-00276
Device Sequence Number1
Product Code GKT
UDI-Device Identifier05020583123205
UDI-Public05020583123205
Combination Product (y/n)N
PMA/PMN Number
K183081
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup,Followup
Report Date 06/05/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/01/2021
Device Model Number12320
Device Catalogue Number12320
Device Lot Number1907123130
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Initial Date Manufacturer Received 05/13/2020
Initial Date FDA Received06/05/2020
Supplement Dates Manufacturer Received09/18/2020
09/29/2020
Supplement Dates FDA Received09/25/2020
10/19/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ASTOTHERM.
Patient Outcome(s) Other;
Patient Age18 MO
Patient Weight10
-
-